“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

The announcement arrives amid a national reshoring wave. U.S. pharmaceutical manufacturing commitments topped $475 billion last year, according to real estate firm JLL – driven by a post-COVID push to ...

The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit requests to take part in the program. Companies are limited to one submission ...

Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

The FDA launched PreCheck pilot program to strengthen U.S. drug supply chain by improving regulatory predictability.

The pharmaceutical industry relies heavily on its supply chain, but this chain can also have a significant environmental impact due to common factors like high emissions or packaging waste.

Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

DUBAI, 9th February, 2026 (WAM) -- Saeed bin Mubarak Al Hajeri, Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, today officially launched the Emirates Drug ...